Market news
Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.
LEXINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging ...
Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.
Detailed price information for Teleflex Inc (TFX-N) from The Globe and Mail including charting and trades.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
- VY7523 clinical data and VY1706 clinical entry, both in Alzheimer’s, expected Q4 2026 - - Ended Q2 2026 with cash position of $149 million, runway into 2028 - LEXINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today reported second quarter 2026 financial and operating results. “We view tau as a critical disease-modifying target in Alzheimer’s disease, and we beli
Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.